{"domain":"orchidhealth.com","status":"valid","tier":"listed","authority":51,"verified":false,"title":"Orchid Health","summary":"Orchid provides whole genome embryo screening for families undergoing IVF. Our technology reads >99% of an embryo's genome, combining chromosomal screening (PGT-A), single-gene disorder screening (PGT-M) for 1,700+ conditions, and polygenic risk scoring — using 100x more data than standard preimplantation genetic testing.","country":"US","country_source":"ip","llms_txt":"https://www.orchidhealth.com/llms.txt","llms_full_txt":"https://www.orchidhealth.com/llms-full.txt","last_checked":"2026-10-21T11:29:14.972Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["embryo-screening","whole-genome-sequencing","ivf","pgt-a","pgt-m","genetic-testing"],"audience":"consumers","agent_uses":["read_docs"],"language":"en","platform_generated":false,"agent_summary":"Whole genome embryo screening for IVF families: Embryo Report ($2,500/embryo), couple genetic report ($998), and PGT-M covering 1,700+ single-gene conditions.","llms_txt_cached":"https://agentwebmap.com/v1/domain/orchidhealth.com/llms.txt","agentic":"documentation","section_keys":["about","for-clinicians","for-patients","key-facts","products"],"section_partial":false,"section_indexed_at":"2026-10-21T14:17:26.300Z"}